Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Long-Term Debt Repayments (2023 - 2025)

Perspective Therapeutics (CATX) has disclosed Long-Term Debt Repayments for 5 consecutive years, with $13000.0 as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Repayments rose 8.33% to $13000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52000.0 through Dec 2025, up 8.33% year-over-year, with the annual reading at $52000.0 for FY2025, 8.33% up from the prior year.
  • Long-Term Debt Repayments hit $13000.0 in Q4 2025 for Perspective Therapeutics, roughly flat from $13000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $21000.0 in Q3 2023 to a low of $8000.0 in Q2 2024.
  • Historically, Long-Term Debt Repayments has averaged $14000.0 across 3 years, with a median of $13000.0 in 2025.
  • Biggest five-year swings in Long-Term Debt Repayments: plummeted 60.0% in 2024 and later soared 62.5% in 2025.
  • Year by year, Long-Term Debt Repayments stood at $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then rose by 8.33% to $13000.0 in 2025.
  • Business Quant data shows Long-Term Debt Repayments for CATX at $13000.0 in Q4 2025, $13000.0 in Q3 2025, and $13000.0 in Q2 2025.